Paul L. Barclay
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Oncology
- Endocrinology, Diabetes and Metabolism
- Cellular and Molecular Neuroscience
- Co-authors
- John C. BurnettJ. B. C. FindlayKenneth B. MarguliesN B SheppersonJohn C. DanilewiczKim JamesChristopher LiddleBertil Ekman
- Topics
- Heart Failure Treatment and Management (8 papers)Peptidase Inhibition and Analysis (7 papers)Atrial Fibrillation Management and Outcomes (3 papers)
- Cited by
- Cardiology and Cardiovascular MedicineEndocrinology, Diabetes and MetabolismCellular and Molecular Neuroscience
- Journals
- JAMACirculationBiochemistry
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Paul L. Barclay
17 papers receiving 348 citations
Peers
Comparison fields: 5 of 76
- Cardiology and Cardiovascular Medicine 144
- Molecular Biology 110
- Oncology 94
- Endocrinology, Diabetes and Metabolism 87
- Cellular and Molecular Neuroscience 80
Countries citing papers authored by Paul L. Barclay
This map shows the geographic impact of Paul L. Barclay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Barclay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Barclay more than expected).
Fields of papers citing papers by Paul L. Barclay
This network shows the impact of papers produced by Paul L. Barclay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Barclay. The network helps show where Paul L. Barclay may publish in the future.
Co-authorship network of co-authors of Paul L. Barclay
This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Barclay. A scholar is included among the top collaborators of Paul L. Barclay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Barclay. Paul L. Barclay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 58 | |
| 2 | 9 | |
| 3 | 44 | |
| 4 | 24 | |
| 5 | 40 | |
| 6 | 6 | |
| 7 | 21 | |
| 8 | 5 | |
| 9 | 13 | |
| 10 | 28 | |
| 11 | The natriuretic and diuretic efficacy of atriopeptidase inhibitors following intravenous and oral administration. | 1 |
| 12 | 53 | |
| 13 | Atriopeptidase inhibitors a novel class of drugs that raises levels of endogenous atrial natriuretic factor the preclinical pharmacology of uk 69578 | 10 |
| 14 | 2 | |
| 15 | 24 | |
| 16 | 29 | |
| 17 | 3 | |
| 18 | 0 |
About Paul L. Barclay
Paul L. Barclay is a scholar working on Cardiology and Cardiovascular Medicine, Transplantation and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 370 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (8 papers), Peptidase Inhibition and Analysis (7 papers) and Atrial Fibrillation Management and Outcomes (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (144 citations), Endocrinology, Diabetes and Metabolism (87 citations) and Cellular and Molecular Neuroscience (80 citations). Paul L. Barclay has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include John C. Burnett, J. B. C. Findlay, Kenneth B. Margulies, N B Shepperson, John C. Danilewicz, Kim James, Christopher Liddle, Bertil Ekman, I. T. Barnish and Martin Wythes. Their work appears in journals such as JAMA, Circulation and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.